Novel Therapeutic Concepts for Complex Femoropopliteal Lesions Using the Jetstream Atherectomy System

Dalibor Dukic1, Klaus Martin1, Michael Lichtenberg2

  • 1Department of Cardiology & Vascular Medicine, Fürst-Stirum-Klinik Bruchsal, Bruchsal, Germany.

Insights

Rotational atherectomy with drug-coated balloons effectively treats severe arterial calcification in leg arteries, improving limb function and reducing re-treatment needs.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Endovascular Therapy

Background:

  • Severe arterial calcification complicates femoropopliteal interventions, leading to poorer outcomes.
  • Rotational atherectomy offers a method for preparing calcified lesions.

Purpose of the Study:

  • To evaluate the safety and efficacy of rotational atherectomy followed by drug-coated balloon angioplasty in complex, calcified femoropopliteal lesions.
  • To assess clinical outcomes up to 12 months post-procedure.

Main Methods:

  • Prospective, single-center observational study of 162 patients with chronic limb ischemia (Rutherford 1-5).
  • Treatment involved Jetstream Atherectomy followed by drug-coated balloon angioplasty.
  • Lesion calcification (PACSS) and complexity (TASC) were assessed; outcomes analyzed up to 12-month follow-up.

Main Results:

  • 99% procedural success with 7.4% bail-out stenting in complex TASC C/D lesions.
  • Significant improvement in Rutherford classification and Ankle-Brachial Index (ABI) at 12 months.
  • High rates of freedom from target lesion revascularization (92.6%) and target vessel revascularization (95.1%) were observed.

Conclusions:

  • Combination therapy of rotational atherectomy and drug-coated balloons is safe and effective for long, calcified femoropopliteal lesions.
  • Favorable mid-term clinical results support an endovascular-first approach for complex lesions.
Abstract

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
233
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
15
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
208
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
17
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
14
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
13